Page last updated: 2024-09-03

1,25-dihydroxyergocalciferol and Angiogenesis, Pathologic

1,25-dihydroxyergocalciferol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grygorowicz, MA; Kotlarz, A; Kutner, A; Markowicz, S; MiƂoszewska, J; Przybyszewska, M; Swoboda, P1

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Angiogenesis, Pathologic

ArticleYear
Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4

    Topics: Antimetabolites, Antineoplastic; Calcitriol; Cell Self Renewal; Cell Survival; Colonic Neoplasms; Dihydroxycholecalciferols; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Ergocalciferols; Fluorouracil; Gene Expression; HCT116 Cells; HT29 Cells; Humans; Neoplastic Stem Cells; Neovascularization, Pathologic

2016